Three lines of evidence for triglycerides as a CV risk factor
Video navigation menu
- Epidemiological evidence for triglycerides as a CV risk factor 0:22
- Genetic evidence 3:30
- The ultimate proof: interventional trial evidence 4:46
This educational video is part of a series called '4 Things a cardiologist needs to know about triglycerides' that is aimed to guide cardiologists in how triglycerides affect CV risk and how patients with high triglyceride levels can be managed according to recent insights.
Ph. Gabriel Steg is a cardiologist in the Hôpital Bichat, Paris, France. He is also Professor at the National Heart and Lung Institute, Imperial College, London, UK.
This educational series is funded by an unrestricted educational grant provided by Amarin.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: